CZ EN RU

News


FARMAK succeeded in the Czech 100 Best competition. It won two important awards

FARMAK succeeded in the Czech 100 Best competition. It won two important awards

16. 12. 2024

On Friday, December 6, 2024, the 29th edition of the prestigious Czech 100 Best competition, organized annually by the Pan-European Society for Culture, Education and Scientific and Technical Cooperation Comenius, took place at the Municipal House in Prague. The competition aims to reward companies and...


read more

Street Art at FARMAK

Street Art at FARMAK

03. 10. 2023

At the end of summer, the traditional Street Art Festival takes place in Olomouc, Czech Republic, FARMAKs hometown. The company has supported the creation of street art works not only in the form of a sponsorship donation, but is also directly in the centre of the festival. It provided a wall for the...


read more

Let's meet at CPHI 2023 in Barcelona

Let's meet at CPHI 2023 in Barcelona

22. 08. 2023

From 23 - 26 October, the biggest pharmaceutical industry event in Europe - CPHI Worldwide 2023 - will take place in Barcelona. Our sales team, colleagues from business development, R&D and other company representatives will also be heading to this traditional trade fair. FARMAK and its team will...


read more

FARMAK, a.s. focused on nuclear magnetic resonance in the study of small molecules

FARMAK, a.s. focused on nuclear magnetic resonance in the study of small molecules

01. 06. 2023

Nuclear magnetic resonance spectroscopy (NMR) is a powerful analytical tool used in API (active pharmaceutical ingredient) research and development by pharmaceutical companies worldwide. FARMAK, a.s., specializing in the production of so-called "generic" APIs, uses NMR technology to study the chemical...


read more

We expect a significant breakthrough in the field of ophthalmology

We expect a significant breakthrough in the field of ophthalmology

18. 04. 2023

The clinical company LENZ Therapeutics has successfully entered the third phase of development in innovative ophthalmological pharmaceutical products aimed at improving vision, specifically for the treatment presbyopia. The development is primarily focused on aceclidine eye drops, which Lenz Therapeutics...


read more

FARMAK, a.s. supports innovative research and actively collaborates on scientific projects

FARMAK, a.s. supports innovative research and actively collaborates on scientific projects

22. 03. 2023

FARMAK, a.s. and the Palacký University's research institute CATRIN (Czech Advanced Technology and Research Institute) have been cooperating for many years. FARMAK, a.s. very often takes part in specialised projects which focus on providing developing opportunities to young students and support new...


read more

The final part of ‘History Sneak Peek’

The final part of ‘History Sneak Peek’

06. 02. 2023

Construction, development, expansion, modernization. These are the main topics of the last part of the series ‘History Sneak Peek’, which was created to commemorate the 30th anniversary of the Farmak a.s. foundation. Let’s wrap up by looking back at important milestones of the company, which should...


read more

Pharmaceutical newcomers of 2022

Pharmaceutical newcomers of 2022

24. 01. 2023

Modern, innovative medicines were introduced to the pharmaceutical market in 2022 and thanks to them the market experienced major changes. The Food & Drug Administration approved a total of 37 new drugs last year. Why does the number of approved drugs plummet year on year? Let's look at what's happening...


read more

The rule of 'quality is more important than quantity' applies in pharmacy too

The rule of 'quality is more important than quantity' applies in pharmacy too

09. 01. 2023

FARMAK a.s. is one of the most important employers in the pharmaceutical industry in the Olomouc Region. In 2022, FARMAK a.s. celebrated its 30th anniversary since it was established, and overcame the aftermath of the coronavirus pandemic. In 2023 we have another challenge ahead of us. This time we face...


read more

Glaucoma - A Silent Sight Killer

Glaucoma - A Silent Sight Killer

02. 12. 2022

Untreated glaucoma can lead to loss of vision   Glaucoma is a multifactorial eye disease characterised by progressive degeneration of ganglion cells of the retina (neuropathy) and causes irreversible loss of the field of view. This leads to blindness as the optic nerve is responsible for bringing...


read more

Back to history - Construction of the Year 2004

Back to history - Construction of the Year 2004

24. 11. 2022

For FARMAK, a.s. 2004 was one of the most important historical milestones. It was in the name of construction and reconstruction. As the company grew, a new production unit had to be built in building No. 33 (Unihala). It was also necessary to upgrade the unsatisfactory premises of building No. 13....


read more

Will Rho kinase inhibitors help to prevent vision loss caused by glaucoma?

Will Rho kinase inhibitors help to prevent vision loss caused by glaucoma?

21. 10. 2022

The primary open-angle glaucoma is an eye disease, which is the second most common cause of vision loss, according to the World Health Organization (WHO).  This disease affects almost 58 million people in the world, 2 to 5% of the Czech population. A number of research teams are trying to discover drugs...


read more

Founder of FARMAK, a.s. Jiří Žák awarded by the Czech Industry and Transport Association

Founder of FARMAK, a.s. Jiří Žák awarded by the Czech Industry and Transport Association

18. 10. 2022

Czech Industry and Transport Association during its assembly at International Engineering Fair, which took place on October 4th in Brno, honored important representatives of Czech industry. Jiří Žák, founder of FARMAK, a.s. entered Gallery of Industry Personalities. He received award from hands of...


read more

Back to history - Devastating floods in 1997

Back to history - Devastating floods in 1997

06. 10. 2022

 Once again, let us have a look into the FARMAK history; today, it is a key event of the 1990s. It has affected almost everyone of us, directly or indirectly, and with a hint that it concerns the year 1997, you will probably know. The following lines are personal memories of FARMAK’s owner, Ing....


read more

Open Day - 30 years of FARMAK, a.s.

Open Day - 30 years of FARMAK, a.s.

22. 09. 2022

September this year is an important month for us, as we celebrated the 30th anniversary of the company's founding. We did not just let this anniversary go unnoticed but shared it with you, our employees, business partners and the public. On Friday, September 9, 2022, we held a press conference with...


read more

Back to history - 30 years of FARMAK, a.s.

Back to history - 30 years of FARMAK, a.s.

13. 09. 2022

Did you know that FARMAK, a.s. celebrates 30 years anniversary this year? With connection to this, we have prepared a special historical series in which the most important milestones and crucial events will be presented. The series will be presented at our Facebook and LinkedIn, but you will find some...


read more

Gold medal from EcoVadis Social Responsibility rating in 2021

Gold medal from EcoVadis Social Responsibility rating in 2021

09. 03. 2022

FARMAK, a.s. is very glad to present Gold medal from EcoVadis Social Responsibility rating in 2021. With score of 68/100, we took place within 6% of best rated companies in industry! We are pharmaceutical company exporting products to more than 50 countries around the world and therefore, we are aware...


read more

DCAT WEEK 2022! MARCH 21-24, NEW YORK

DCAT WEEK 2022! MARCH 21-24, NEW YORK

18. 02. 2022

Coming to NYC for the world's most famous pharma networking event? Meet FARMAK, a.s. at The Kimberly Hotel! Feel free to contact us at info@farmak.cz


read more

Important changes in FARMAK, a.s.

Important changes in FARMAK, a.s.

28. 01. 2022

We are pleased to inform about important changes in our company that came into force since beginning of 2022. FARMAK, a.s. has been transformed to a so called German model of Joint-Stock company (Aktiengesellschaft), which means that the main inspecting organ is now Supervisory Board. Mr. Jiří Žák...


read more

FARMAK, a.s. won Czech Leaders Awards competition in Olomouc region 2021

FARMAK, a.s. won Czech Leaders Awards competition in Olomouc region 2021

16. 12. 2021

FARMAK, a.s. took first place as a leader of Olomouc region in Czech Leaders Awards competition!This year, 1529 mostly family-business Czech companies with more than 50 employees and annual turnover at least 200 million (CZK) attended Leaders Awards competition. As founder of the project Helena Kohoutová...


read more

Previous page / Next page (1/2)
Novinky - výpis všech